All blog items

A new Duke Health training program aimed at meeting primary care shortage needs in rural North Carolina has been approved by the ACGME Residency Review Committee. Now accredited, the program will enter the 2021 National Resident Matching Program (NRMP) Main Residency Match® with two spots.

Veteran Duke scientist and executive R. Sanders “Sandy” Williams has been named interim Vice President for Research and Innovation at Duke

Research from Duke University and UNC-Chapel Hill suggests that schools can consider returning to in-class instruction if they mitigate COVID-19 transmission on campuses

Nadine Barrett, Ph.D., will lead the community-engaged project “Race and COVID-19: Outcomes that Matter to the Black Community.

Dean Klotman talks with infectious disease specialists about potential issues surrounding variant strains that have emerged in the COVID-19 virus.

As the race to produce and roll out COVID-19 vaccines around the world continued to ramp up, global health experts from four continents met with DGHI to discuss vaccine equity and allocation.

Postdoctoral fellow Binita Chakraborty, PhD, was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standard of care, the treatment worked better in men than in women. “There may be multiple reasons why the response may be different between males and females,” she says. “But one of the biggest differences that stands out was circulating estrogen levels. Estrogen levels are much higher in females than males.”

Researchers at Duke and Mt. Sinai have identified a molecular mechanism that prevents a viral infection during a mother’s pregnancy from harming her unborn baby.

New theory uses physics to predict the growth stages of cancerous tumors

One of the things that COVID has taught us is how inadequate our systems are to meet the requirements of a pandemic, including just the exchange of information.